Expertise areas

Across our academic faculty, the GBSH collectively has over 100 areas of research expertise across the business of health field. With subject areas of knowledge ranging from health economics to healthcare AI right through to mergers and acquisitions, we are well placed to make real impact for your organisation.

Subject areas include but are not limited to:

• Global Health Systems
• Integrated healthcare
• Political Economy of Health
• Macroeconomic Policies and health
• Hybrid leadership development
• Human resource development
• Healthcare management 
• Strategic leadership
• Ethnic minority microbusinesses
• Qualitative research methods
• The business of business schools
• Equity, diversity, inclusion, and impact
• Human resources in health
• Women leadership
• Power and health
• Social responsibility of pharmaceutical industry and pharmacists during crises
• The role of tribal culture in pharmacy services in tribal nations 
• The role of diversity and integration of economic migrants in healthcare through pharmacists 
• Access to medicine for disadvantaged communities in underprivileged countries 
• Available public data and use for development
• Data analysis methods: Statistics to deep learning
• AI for Healthcare: development and application of AI methods to analyse hospital electronic health records to design interventions and improve patient outcomes
• Complexity science: complex system approaches for integrated health system analysis
• Topological data analysis: theory and application of graphs and simplicial complex representations of complex systems, e.g. patient clinical space and their evolution, to identify salient structures
• Fundamental neuroscience: emergence and complexity of brain function and cognition
• Value-Based Health Care
• Operations Management
• Supply Chain Management
• Organisational social networks, with focus on their individual and organisational determinants, and on dynamics and consequences.
• Collaboration and knowledge sharing among professionals in organisational settings, communities of practice and atypical work contracts (e.g., freelancers)
• Evolving space of deep learning regulations (international markets)

• Future of work, specifically flexible work-arrangements (i.e., remote work, hybrid work) and their impact on knowledge sharing dynamics 
• Financial accounting, financial reporting quality, audit quality
• Accounting sustainability
• Management accounting, cost accounting
• Corporate governance
• Public sector accounting, healthcare accounting
• Corporate Finance
• Mergers and Acquisitions, Deal activities
• Corporate Governance
• Institutional Investors
• Corporate Social Responsibility
• Environmental, Social and Governance (ESG) 
• Sustainability/Climate Change
• Emerging Markets/Developing countries
• Corporate Culture, and National Culture
• Financial Regulations
• Consumer behaviour in the context of healthcare
• Personalisation of healthcare interventions for improved acceptance
• Promoting behaviour change for disease prevention and health promotion (with most experience in relation to cancer prevention and early cancer diagnosis)
• Optimising consumer/user experience in the context of healthcare interventions or healthcare services interactions
• Personalisation of healthcare technology (e.g., wearables, sensors, monitoring devices)
• Optimising user experience (UX) of healthcare technology (e.g., wearables, sensors, monitoring devices)
• Developing and optimising artificial intelligence (AI)  applications for user-facing healthcare technology (user interfaces, digital marketing, wearables and other devices)
• Optimising user/consumer acceptance and commercial performance of various healthcare solutions
• Health economics in LMICs 
• Healthcare financing and delivery in LMICs
• Public health insurance in LMICs
• Gender and socioeconomic inequalities in health
• Cloud compute vs local decision support

• Using Quality by Design principles for medicine development  
• Taste masking of bitter drugs for paediatric medicine development 
• Taste assessment of pharmaceuticals, especially using an E-tongue 
• Using machine learning and AI for taste prediction  
• Nanofabrication methods including electrospinning and electrospraying for various pharmaceutical applications 
• Using multi-axial electrospinning for stabilisation and development of proteins for oral drug delivery 
• Commercialization of healthcare services especially through community pharmacies
• Mobilisation of pharmacists to improve healthcare outcomes in LMICs 
• Marketing strategies of public health campaigns in LMICs, and general commercial determinants of health
• Ethics and regulation of marketing of medical tourism and telemedicine  
• Financial Econometrics
• M&As and Market for Corporate Control
• Corporate Finance
• Risk and Portfolio analysis 
• Fintech as innovation
• Responsible Artificial Intelligence (AI)
• Financial Inclusion and well-being
• Sustainability and Circular Economy
• Computational Analytics
• Universal Health Coverage
• Healthcare for migrants
• COVID-19 government policy response (inc. vaccine programme)
• Human behaviour during and public opinion towards COVID-19 
• Health system capacity and performance 
• Chinese healthcare politics and political economy for health
• The role of the private sector in the health system  
• Healthcare markets in LMICs
• Health care financing 
• Economic Analysis 
• Global Health 
• Human wellbeing
• Human-AI Interaction 
• Behavioural Science 
• Human Factors 
• Health Psychology
• Infection Prevention and Control 
• Health & Migration
• Money, inflation & funding of public policies
• Cost-Benefit Analysis
• Image analysis and formats, rules and regulations around their use for commercial purposes 

Find the solution to your problem

Interested to find out more about how we can support your organisation's needs? Contact us and our team will follow up to set up an initial consultation and explore options with you.

Contact us